2.11
price up icon4.46%   0.09
after-market Handel nachbörslich: 2.09 -0.02 -0.95%
loading

Iovance Biotherapeutics Inc Aktie (IOVA) Neueste Nachrichten

pulisher
Sep 27, 2025

Is Iovance Biotherapeutics Inc 2LB a good long term investmentStock Market Trends & Access Free Tools and Start Investing - Early Times

Sep 27, 2025
pulisher
Sep 27, 2025

Is Iovance Biotherapeutics Inc a good long term investmentCapital Gains Strategies & Free Hedging Tactics for Volatile Markets - Early Times

Sep 27, 2025
pulisher
Sep 27, 2025

Iovance Biotherapeutics Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo

Sep 27, 2025
pulisher
Sep 26, 2025

Iovance Biotherapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - 富途牛牛

Sep 26, 2025
pulisher
Sep 26, 2025

Iovance Biotherapeutics (NASDAQ:IOVA) Share Price Passes Below Two Hundred Day Moving AverageWhat's Next? - MarketBeat

Sep 26, 2025
pulisher
Sep 25, 2025

Healthcare's Convergence Accelerates as Aging Demographics Meet Breakthrough Therapies - Baystreet.ca

Sep 25, 2025
pulisher
Sep 21, 2025

Assessing Iovance Biotherapeutics (IOVA) Valuation Following Key Strategic Updates and Growth Plans - Sahm

Sep 21, 2025
pulisher
Sep 21, 2025

Revenue Check: Can Iovance Biotherapeutics Inc deliver consistent EPS growthTrade Entry Report & AI Enhanced Execution Alerts - خودرو بانک

Sep 21, 2025
pulisher
Sep 21, 2025

Iovance Biotherapeutics (NASDAQ:IOVA) Share Price Crosses Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

Iovance Biotherapeutics, Inc. (IOVA): Among Stocks Under $10 that Will Triple - MSN

Sep 20, 2025
pulisher
Sep 20, 2025

Published on: 2025-09-21 02:39:03 - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Buy Signal: Can Iovance Biotherapeutics Inc grow without dilutionJuly 2025 Retail & AI Enhanced Execution Alerts - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Valuation Update: Will Iovance Biotherapeutics Inc benefit from AI trendsMarket Activity Recap & Weekly Return Optimization Plans - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

Sep 20, 2025
pulisher
Sep 20, 2025

Iovance Biotherapeutics, Inc. (IOVA) Targeting $1B on Amtagvi Sales amid Cost Cuts - Insider Monkey

Sep 20, 2025
pulisher
Sep 19, 2025

22,810 Stock Options at $2.20: Iovance Biotech Expands Team with New Employee Inducement Grants - Stock Titan

Sep 19, 2025
pulisher
Sep 19, 2025

Returns Recap: Is Iovance Biotherapeutics Inc likely to announce a buybackDollar Strength & Low Risk High Reward Ideas - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Decliners Report: Will Iovance Biotherapeutics Inc benefit from green energy policiesTrade Analysis Report & Weekly Watchlist of Top Performers - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Can This Beaten-Down Stock Bounce Back? - Yahoo Finance

Sep 19, 2025
pulisher
Sep 19, 2025

Ema's CHMP recommended five extensions of indication for medicines Bimervax, Dupixent, Keytruda - MarketScreener

Sep 19, 2025
pulisher
Sep 18, 2025

Earnings Recap: Why is Iovance Biotherapeutics Inc stock going upJuly 2025 Earnings & Real-Time Buy Signal Alerts - خودرو بانک

Sep 18, 2025
pulisher
Sep 17, 2025

Advancing Cancer Research Brings New Hope for Patients Worldwide - Benzinga

Sep 17, 2025
pulisher
Sep 17, 2025

Bearish Setup: Can Iovance Biotherapeutics Inc stock double in the next yearJuly 2025 Trade Ideas & Scalable Portfolio Growth Ideas - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

Sectors Review: Is Iovance Biotherapeutics Inc attractive at current valuationFed Meeting & Free Long-Term Investment Growth Plans - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Why Iovance Biotherapeutics (IOVA) Is Up 8.2% After Health Canada Approves Amtagvi for Melanoma - Sahm

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Chart Watch: Is Iovance Biotherapeutics Inc being accumulated by smart moneyGap Up & Weekly Top Performers Watchlists - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Iovance Biotherapeutics Updates Corporate Presentation - MSN

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Breakouts: Is Iovance Biotherapeutics Inc forming a bullish divergenceQuarterly Trade Report & Consistent Profit Trading Strategies - khodrobank.com

Sep 16, 2025
pulisher
Sep 16, 2025

Fibrogen leads drug developer stock gains on China sale, FDA update - BioWorld MedTech

Sep 16, 2025
pulisher
Sep 16, 2025

Is Iovance Biotherapeutics Inc showing insider buyingTrade Entry Report & Expert-Curated Trade Recommendations - khodrobank.com

Sep 16, 2025
pulisher
Sep 15, 2025

Nasdaq Moves: How does Iovance Biotherapeutics Inc score in quality rankingsJuly 2025 Highlights & Entry and Exit Point Strategies - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Published on: 2025-09-16 06:42:56 - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Entry Recap: Should I buy Iovance Biotherapeutics Inc. stock now2025 Technical Patterns & Weekly High Conviction Ideas - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Market Overview: Can Iovance Biotherapeutics Inc. maintain sales growth2025 Retail Activity & Stepwise Swing Trade Plans - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Stock Analysis: Why is Iovance Biotherapeutics Inc stock going upJuly 2025 Rallies & Capital Protection Trading Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Bull Run: Will Iovance Biotherapeutics Inc benefit from AI trends2025 Geopolitical Influence & Entry and Exit Point Strategies - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

RSI Check: What are Iovance Biotherapeutics Inc.’s earnings expectationsEarnings Beat & Real-Time Volume Analysis - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Iovance falls after missing Q2 expectation - MSN

Sep 15, 2025
pulisher
Sep 14, 2025

Jacobs Levy Equity Management Inc. Invests $4.19 Million in Iovance Biotherapeutics, Inc. $IOVA - MarketBeat

Sep 14, 2025
pulisher
Sep 14, 2025

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Average Rating of "Hold" by Brokerages - MarketBeat

Sep 14, 2025
pulisher
Sep 12, 2025

Iovance Biotherapeutics, Inc. $IOVA Position Cut by American Century Companies Inc. - MarketBeat

Sep 12, 2025
pulisher
Sep 11, 2025

Why Iovance Biotherapeutics Stock Plummeted Today - MSN

Sep 11, 2025
pulisher
Sep 10, 2025

Invenomic Capital Management LP Purchases Shares of 5,489,799 Iovance Biotherapeutics, Inc. $IOVA - MarketBeat

Sep 10, 2025
pulisher
Sep 09, 2025

Iovance Biotherapeutics at H.C. Wainwright Conference: Strategic Growth and Efficiency - Investing.com Canada

Sep 09, 2025
pulisher
Sep 09, 2025

Growth Review: Will Iovance Biotherapeutics Inc. stock go up in YEARRisk Management & Stepwise Swing Trade Plans - Lancaster City Council

Sep 09, 2025
$20.95
price up icon 3.41%
$82.70
price up icon 1.27%
$29.07
price up icon 0.80%
$98.08
price up icon 0.00%
$137.03
price up icon 1.06%
biotechnology ONC
$326.06
price down icon 0.81%
Kapitalisierung:     |  Volumen (24h):